Clinical systems · AI-powered virtual neurology
Sevaro
Sevaro provides AI-powered virtual neurology and telestroke coverage for hospitals, with Synapse AI for workflow and analytics beside its clinician network.
Strong fit
- Hospitals that need 24/7 telestroke and acute neurology coverage without hiring a full neurologist bench
- Stroke programs that want Synapse AI analytics beside virtual neurologists
- Health systems expanding neurohospitalist, EEG, and neuro-ICU coverage to more sites
Weak fit
- Outpatient clinics shopping only for a consumer telehealth app
- Hospitals that have surplus in-house neurology at every campus
- Buyers who need a published per-consult price list
Bottom line
Sevaro is a physician-led virtual neurology company that pairs hospital telestroke and neurohospitalist coverage with its Synapse AI platform for workflow and analytics. It raised a $39 million Series B in 2025 to expand the specialty care platform. It fits hospitals that need reliable neurology coverage and want AI tools that sit with the clinical service rather than as a separate imaging toy.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Raj Narula, MD, founded Sevaro and serves as CEO. The company name blends Sanskrit roots for selfless service.
Sevaro provides virtual stroke and acute neurology, neurohospitalist rounding, remote EEG reads, neuro-intensive care support, neuro-rehab, and outpatient neurology clinics. Its Synapse AI adds workflow help and analytics across neurology care.
Clinical leaders include vascular neurologists and people who run stroke programs. Carl Dugart is CTO.
In September 2025 Sevaro closed an oversubscribed $39 million Series B led by Valtruis and Intermountain Ventures.
Sevaro's pitch is faster stroke response, 24/7 coverage without overloading local teams, and care guided by Synapse AI data. The buyer is a hospital or health system stroke and neurology program, not a consumer downloading an app.
TeleSpecialists fits when you want another physician-owned partner for remote neurology and stroke coverage. RapidAI or Nicolab fit when the main need is stroke imaging AI rather than physician coverage.
Caregility fits when you need a broader telehealth platform across many specialties instead of a neurology service.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| RapidAI | 8.1 | 7.6 |
| Sevaro | 7.4 | 7.2 |
| TeleSpecialists | 6.9 | 6.8 |
| Caregility | 6.8 | 6.6 |
Pricing
| Item | Detail |
|---|---|
| Model | A hospital service contract quoted by Sevaro for each coverage line and Synapse AI module. |
| What usually drives cost | Which services you buy (stroke and acute neurology, neurohospitalist rounding, remote EEG, neuro-ICU, rehab, outpatient), consult volume, number of sites, and analytics modules. |
| What to ask before you buy | Per-consult or coverage-block pricing, what Synapse AI adds, and how overnight and weekend coverage is staffed and billed. |
| Published pricing | Sevaro does not publish a price list. |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.